When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report

Immune-related hepatitis (IRH) is a frequent but poorly understood immune-related adverse event and its frequency increases since the use of combination therapy in several cancer types. Therefore, there is an urgent need to develop adapted guidelines to manage IRH. In the present letter, based on Zi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauci, Marie-Léa, Baroudjian, Barouyr, Lebbe, Celeste, Roux, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996650/
https://www.ncbi.nlm.nih.gov/pubmed/33771893
http://dx.doi.org/10.1136/jitc-2021-002337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996650/
https://www.ncbi.nlm.nih.gov/pubmed/33771893
http://dx.doi.org/10.1136/jitc-2021-002337

Ejemplares similares